相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
Nikhil Hebbar et al.
NATURE COMMUNICATIONS (2022)
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
Ya-Jui Lin et al.
FRONTIERS IN IMMUNOLOGY (2022)
Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
Wei Yu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
Tessa Gargett et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells
Zihang Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death
Guanzheng Liu et al.
CELL DEATH & DISEASE (2021)
First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose
Qingtang Lin et al.
FRONTIERS IN ONCOLOGY (2021)
Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors
Koichi Hirabayashi et al.
NATURE CANCER (2021)
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Glioblastoma precision therapy: From the bench to the clinic
Yuan Zhou et al.
CANCER LETTERS (2020)
State of the art in CAR T cell therapy for CD19+ B cell malignancies
Matthew J. Frigault et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan et al.
NATURE MEDICINE (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment
Kristie Liu et al.
FRONTIERS IN ONCOLOGY (2020)
Nanocarrier-based drug combination therapy for glioblastoma
Mengnan Zhao et al.
THERANOSTICS (2020)
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Dong Yang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Production and Application of Multicistronic Constructs for Various Human Disease Therapies
Alisa A. Shaimardanova et al.
PHARMACEUTICS (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
A Novel Doxorubicin Prodrug with GRP78 Recognition and Nucleus Targeting Ability for Safe and Effective Cancer Therapy
Guo-Bin Ding et al.
MOLECULAR PHARMACEUTICS (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
GRP78 enabled micelle-based glioma targeted drug delivery
Danni Ran et al.
JOURNAL OF CONTROLLED RELEASE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Isocostunolide inhibited glioma stem cell by suppression proliferation and inducing caspase dependent apoptosis
Zhi Dai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cell surface GRP78 as a biomarker and target for suppressing glioma cells
Bo Ram Kang et al.
SCIENTIFIC REPORTS (2016)
Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis
Thanh-Tuan Huynh et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78
Liang Zhao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
Xuekai Zhu et al.
ONCOTARGET (2015)
Emerging treatment strategies for glioblastoma multiforme
Steven K. Carlsson et al.
EMBO MOLECULAR MEDICINE (2014)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Christine E. Brown et al.
PLOS ONE (2013)
Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
Seogkyoung Kong et al.
CLINICAL CANCER RESEARCH (2012)
Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways
Lu-Hua Zhang et al.
BRAIN RESEARCH (2011)
Inhibition of NF-κB1 and NF-κB2 activation in prostate cancer cells treated with antibody against the carboxyl terminal domain of GRP78: Effect of p53 upregulation
U. K. Misra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells
Uma K. Misra et al.
CANCER BIOLOGY & THERAPY (2010)
Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen
Masasuke Ohno et al.
CANCER SCIENCE (2010)
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells
Jenilyn J. Virrey et al.
MOLECULAR CANCER RESEARCH (2008)
GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis
Hae Kyung Lee et al.
NEURO-ONCOLOGY (2008)
GRP78 and cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth
Gidi Shani et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Activation and cross-talk between Akt, NF-κB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78
UK Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
MA Arap et al.
CANCER CELL (2004)
分享论文
